Bertil RR Persson

Scandinavian ChemoTech AB. Sweden

Bertil R.R. Persson, Professor emeritus. Full Professor in Medical Radiation Physics at the University of Lund and 25 years’ head of the Clinical Department at the University Hospital. Tutor of 40 doctoral dissertations on the faculties of medicine and science. Cofounder of Scandinavian ChemoTech AB. Sweden.

Out of more than 400 scientific publications, and 20 books, the most relevant for this presentation is “A new Brain Tumor Therapy Combining Bleomycin with in vivo Electro-permeabilization" published in 1993, together with the neurosurgeon Leif G. Salford (Lund, Sweden) and Lluis Mir (Paris, France). The result showed prolonged survival, and that in two out of seventeen treated animals their implanted brain tumour eradicated.

Other well-cited publications are about “Blood-Brain Barrier Permeability and Nerve cell damage in mammalian brain after exposure to microwaves from mobile phones," from the collaboration with Leif G. Salford. Also, the publications about radioecology, and radioactive Polonium-210 are well cited.

dont miss

Dynamic-ElectroEnhanced Chemotherapy brings relief to patients with large tumour burden

A new concept of Dynamic-ElectroEnhanced Chemotherapy™, the D-EECT protocol, applied in clinical case studies in India with IQWave™ device. The results of treating patients with breast cancer were almost equal to the old ESOPE protocol. Considering squamous cell carcinoma (SCC) tumours larger than 3 cm, the treatment response is without progressive disease with the D-EECT protocol, while treatments according to ESOPE protocol report an average of about 5% progressive disease.


  • Professor Noel Clarke: Speaking at the Oncology Convention

    Professor Noel Clarke
    The Christie and Salford Royal Hospitals, Manchester UK

    Improving Prostate Cancer Outcomes Through Cancer Trials

  • Chris Carrigan: Speaking at the Oncology Convention

    Chris Carrigan
    Bowel Cancer Intelligence UK

    Patient Engagement in the uses of Patient Data

  • Malcolm Wilson: Speaking at the Oncology Convention

    Malcolm Wilson
    The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester

    Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours

  • Prof Ingunn Holen: Speaking at the Oncology Convention

    Prof Ingunn Holen
    Department of Oncology and Metabolism, University of Sheffield, UK

    Tumour cell dormancy and breast cancer relapse

  • Professor Robert Thomas: Speaking at the Oncology Convention

    Professor Robert Thomas
    Bedford and Addenbrooke's Cambridge University Hospitals

    Evidence based lifestyle strategies after cancer - a research review